Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you prescribe GLP-1s for weight gain from aromatase inhibitors?
Related Questions
What is an acceptable upper limit for ipsilateral lung V8 Gy when using the Fast Forward regimen with high tangents to cover limited axillary disease?
Is it appropriate to use bolus with hypofractionated PMRT?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
How do you assess and counsel women with chronic post-lumpectomy or mastectomy pain?
Is ultrahypofractionation appropriate for a B51 candidate receiving breast-only radiation?
In a young woman with large invasive breast carcinoma (case: pT3, lobular) s/p skin sparing mastectomy with positive anterior margin, what is the practical role for re-excision with or without PMRT?
Do you ever treat cervical nodes above the standard supraclavicular field for breast cancer patients?
How does a pathological CR to neoadjuvant chemotherapy influence your practice for the use of bolus with adjuvant PMRT patients without inflammatory breast cancer, but who would meet traditional risk factors for skin involvement?
What volumes and dose would you use for a chest wall recurrence in a patient who had previous mastectomy and completed only a partial prior course of PMRT?